Related Experiment Video
Updated: Jul 9, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Downregulation of miR-3074-5p slows cervical cancer progression by targeting TGFBR2 expression
Xiaoqing Zhu1, Juan Xiang1, Jing Bai1
1Department of Gynecology, Affiliated Central People's Hospital, China Three Gorges University, Yichang Central People's Hospital, Yichang, 443000, China.
Background:
A growing body of evidence suggests that microRNAs (miRNAs) are key regulatory factors in cervical cancer (CC). However, the role and mechanism of action of miR-3074-5p in CC remain unclear.
Objective:
The objective of this research is to elucidate the function of miR-3074-5p in CC.
Methods:
Tumor tissues were collected from 141 CC patients. RT-qPCR was used to detect miR-3074-5p expression. Kaplan-Meier survival curves analyzed the association between the miR-3074-5p and 5-year overall survival rates. Cox regression models evaluated the potential prognostic value of miR-3074-5p. Cell proliferation was assessed using the CCK-8 assay, while cell migration and invasion capabilities were evaluated via Transwell experiments. Dual-luciferase reporter gene assays (DLR) and RNA immunoprecipitation (RIP) experiments identified miR-3074-5p target genes, with Pearson correlation analysis evaluated their associations.
Results:
miR-3074-5p was markedly increased in CC. Its overexpression was closely associated with poor patient prognosis. Inhibiting miR-3074-5p expression effectively attenuated the malignant behavior of CC cells. miR-3074-5p directly targets TGFBR2, with inverse expression patterns confirmed in clinical samples. Rescue experiments demonstrated that TGFBR2 knockdown partially counteracted the tumor-suppressive effects induced by miR-3074-5p inhibition.
Conclusion:
Downregulation of miR-3074-5p suppresses the malignant phenotype of CC cells by targeting TGFBR2. This finding provides initial insights into the cellular behavior of CC.
Insights
Overexpression of miR-3074-5p promotes cervical cancer (CC) progression by targeting TGFBR2. Inhibiting miR-3074-5p may offer a therapeutic strategy for CC patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are implicated as key regulators in cervical cancer (CC).
- The specific role and mechanism of miR-3074-5p in CC pathogenesis are not well understood.
Purpose of the Study:
- To investigate the function and mechanism of miR-3074-5p in cervical cancer.
- To determine the prognostic value of miR-3074-5p in CC patients.
Main Methods:
- Expression analysis of miR-3074-5p in 141 CC tissues using RT-qPCR.
- Correlation analysis between miR-3074-5p levels and patient prognosis (Kaplan-Meier, Cox regression).
- In vitro assays (CCK-8, Transwell) to assess cell proliferation, migration, and invasion; dual-luciferase and RIP assays to identify targets.
Main Results:
- miR-3074-5p expression was significantly elevated in CC tissues and associated with poor prognosis.
- Inhibition of miR-3074-5p suppressed CC cell proliferation, migration, and invasion.
- miR-3074-5p directly targets TGFBR2, exhibiting inverse expression in clinical samples; TGFBR2 knockdown partially reversed the effects of miR-3074-5p inhibition.
Conclusions:
- Downregulation of miR-3074-5p inhibits the malignant phenotype of CC cells by targeting TGFBR2.
- miR-3074-5p serves as a potential diagnostic and therapeutic target for cervical cancer.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
TGF - β Signaling Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...